IL13 and COVID-19: Since coronavirus disease 2019 (COVID-19) is fundamentally characterized by dysregulation of the lung mucosae, we postulate that IL-13 is associated with destructive lung hyperinflammation/immune activity that underpins severe COVID-19 disease progression.